Post Hoc Analyses of Surrogate Markers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Liver Fibrosis in Patients With Type 2 Diabetes in a Digitally Supported Continuous Care Intervention: An Open-Label, Non-Randomised Controlled Study
BMJ Open - United Kingdom
doi 10.1136/bmjopen-2018-023597
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2019
Authors
Publisher
BMJ